Breaking News

Legacy Pharmaceuticals Advances New Russian Track and Trace Regulation

Regulation sets new bar for serialization, compliance reporting, and data management

Legacy Pharmaceuticals announced that preparations to meet the new Russian track and trace regulation, Federal Law No. 425-FZ, are well advanced. Due to be introduced in January 2020, the regulation sets a new bar for serialization, compliance reporting, and data management.    “The Russian regulations are even more stringent that the newly implemented serialization systems that Legacy recently installed to meet the EU Falsified Medicines Directive in 2018. The addition of cryptographic coding...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters